A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William Schelman, MD, PhD
HUTCHMED International
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Arizona
Phoenix, Arizona, United States
- Highlands Oncology
Springdale, Arkansas, United States
- Beverly Hills Cancer Center
Beverly Hills, California, United States
- University of Colorado
Aurora, Colorado, United States
- Florida Cancer Specialists - Fcs South
Port Charlotte, Florida, United States
- Florida Cancer Center North
St. Petersburg, Florida, United States
- Florida Cancer Specialists Panhandle
Tallahassee, Florida, United States
- Florida Cancer Specialists - East (fcs East)
West Palm Beach, Florida, United States
- Hoc Aon Baton Rouge / Sarah Cannon
Baton Rouge, Louisiana, United States
- Messino Cancer Center
Asheville, North Carolina, United States
- Oklahoma University Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
- Women and Infants Hospital of Rhode Island
Providence, Rhode Island, United States
- Tennessee Oncology-Chattanooga
Chattanooga, Tennessee, United States
- Tennesse Oncology
Nashville, Tennessee, United States
- Vanderbilt Ingram Cancer Center
Nashville, Tennessee, United States
- the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Aug 2021
- Primary completion
- 18 Jun 2024
- Completion
- 18 Jun 2024
- Last update posted
- 14 Jul 2025
- Registered enrollment
- 52
- Registry id
- NCT04577963
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.